William Blair & Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History

William Blair & Company’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.6K	Buy	224 +164	+273%	+$17.7K	﹤0.01%	1834
2026 Q1	$6.23K	Hold	60	–	–	﹤0.01%	1860
2025 Q4	$6.27K	Hold	60	–	–	﹤0.01%	1801
2025 Q3	$5.55K	Hold	60	–	–	﹤0.01%	1787
2025 Q2	$4.79K	Hold	60	–	–	﹤0.01%	1767
2025 Q1	$5.2K	Hold	60	–	–	﹤0.01%	1745
2024 Q4	$4.96K	Hold	60	–	–	﹤0.01%	1766
2024 Q3	$5.22K	Hold	60	–	–	﹤0.01%	1781
2024 Q2	$4.93K	Buy	+60	New	+$4.77K	﹤0.01%	1779
2022 Q3	–	Sell	-28	Closed	-$2K	–	1872
2022 Q2	$2K	Hold	28	–	–	﹤0.01%	1842
2022 Q1	$2K	Hold	28	–	–	﹤0.01%	1892
2021 Q4	$2K	Hold	28	–	–	﹤0.01%	1945
2021 Q3	$2K	Hold	28	–	–	﹤0.01%	1856
2021 Q2	$2K	Hold	28	–	–	﹤0.01%	1866
2021 Q1	$2K	Hold	28	–	–	﹤0.01%	1837
2020 Q4	$2K	Hold	28	–	–	﹤0.01%	1797
2020 Q3	$2K	Hold	28	–	–	﹤0.01%	1693
2020 Q2	$2K	Hold	28	–	–	﹤0.01%	1651
2020 Q1	$2K	Buy	+28	New	+$1.71K	﹤0.01%	1627

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

William Blair & Company's PJP Position: Q2 2026 in Review

William Blair & Company increased its Invesco Pharmaceuticals ETF (PJP) stake by 273% in Q2 2026, buying an estimated $17.7K and bringing the position to 224 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

William Blair & Company first reported a position in PJP in Q1 2020 and has held it in 19 quarters since. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

William Blair & Company held 224 shares of Invesco Pharmaceuticals ETF worth $26.6K as of Q2 2026.
William Blair & Company bought 164 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $17.7K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1834 holding.
William Blair & Company first reported a position in Invesco Pharmaceuticals ETF in Q1 2020 and has held it in 19 quarters since.
116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.